PremiumCompany AnnouncementsLilly Targets China’s Obesity Market With New Phase 3 Oral Orforglipron Trial2h agoLLY
PremiumCompany AnnouncementsLilly’s Brenipatide Steps Into Phase 3: A New Long-Term Play in Depression Care2h agoLLY
PremiumCompany AnnouncementsEli Lilly Expands Alzheimer’s Pipeline With New Amyloid Phase 1 Trial1d agoLLY
PremiumCompany AnnouncementsLilly Quietly Expands Its Alzheimer’s Pipeline With New Early-Stage Trial1d agoLLY